Fingerprint
Dive into the research topics of 'Fidaxomicin versus vancomycin for clostridium difficile infection: Meta-analysis of pivotal randomized controlled trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Fidaxomicin versus vancomycin for clostridium difficile infection: Meta-analysis of pivotal randomized controlled trials
Derrick W. Crook*, A. Sarah Walker, Yin Kean, Karl Weiss, Oliver A. Cornely, Mark A. Miller, Roberto Esposito, Thomas J. Louie, Nicole E. Stoesser, Bernadette C. Young, Brian J. Angus, Sherwood L. Gorbach, Timothy E.A. Peto, Klaus Dalhoff
*Corresponding author for this work
- Nuffield Department of Medicine
- Department of Cardiovascular Medicine
- Optimer Pharmaceuticals, Inc.
- Department of Infectious Diseases and Microbiology
- University of Montreal
- Department of Internal Medicine I
- University of Cologne
- Division of Infectious Diseases
- McGill University
- Clinica Delle Malattie Infetive e Tropicali
- University Health Network
- University of Calgary
- Tufts University
119
Citations
(Scopus)